A product that combines pharmaceutical efficacy and food safety is called as a Nutraceutical. It is used to describe foods that have therapeutic or nutritional properties. They have the capacity to attract a lot of customers due to the potential quality of health benefits supplied to the human body. A brief explanation of how these products are regulated in India, along with the schedules, registration process, method of preparation, labelling, claims, and its advantages are clearly explained in this article. A comparison table is prepared comparing various parameters like definition, scope, forms, fees etc. for India, United States, and European Union.
Traditional foods and herbal extracts have been acknowledged as an essential component of the holistic effort to attain total well-being and health throughout history, particularly in the ancient Ayurveda system of medicine in India but also in traditional Chinese, Roman, and Greek medicine. “Let food be thy medicine and medicine be thy food" as Hippocrates (460-377 BC), the well-known father of modern medicine, declared, to emphasize the correlation between suitable foods for nutrition and their therapeutic effects. The guiding principle was “Focus on prevention”. Theophrastus (370–285 BC), Cato (234–149 BC), Pliny the Elder (23–79 AD), and Galan (131–201 AD) all issued statements warning against the adulteration of food products at that time. Since 2000 BC, Schwan has used microorganisms (fungi or yeast) 1837 to produce products through the alcoholic fermentation process. Funk (1884–1967), the father of vitamin therapy, started a new investigation on vitamins and identified them as nutritional required components for the survival of good health. Dr. Stephen L. De Felice, the chairman and founder of the innovation of medicine, coined the word "nutraceuticals." in 1989 by the combination of two words “nutrition” and “pharmaceutical”. Essentially, this is a marketing tool.
Table of Contents
I. Introduction
II. India’s regulation of nutraceuticals
III. Regulatory components for nutraceuticals
IV. Licensing and registration of nutraceuticals
V. Good Manufacturing Practices
VI. Method of preparation of nutraceuticals
VII. Laboratory and sample analysis
VIII. Labelling
IX. Claims and advertisements
X. Recommended Dietary Allowances (RDA) in India
XI. Food safety auditing
XII. Recall guidelines
XIII. India’s nutraceutical marketing growth
XIV. Challenges in nutraceutical market
XV. Future developments
XVI. Comparison of nutraceuticals in US, India, Europe
Research Objectives & Key Thematic Areas
The primary aim of this work is to examine the regulatory framework governing nutraceuticals within the Indian market and to provide a comparative analysis with the frameworks established in the United States and Europe.
- Regulatory landscape and FSSAI standards in India.
- Licensing, registration, and Good Manufacturing Practices (GMP) for nutraceutical producers.
- Methods for sample analysis, laboratory auditing, and product labelling requirements.
- Comparative regulatory assessment between India, the US, and Europe.
Excerpt from the Book
History of nutraceuticals
Traditional foods and herbal extracts have been acknowledged as an essential component of the holistic effort to attain total well-being and health throughout history, particularly in the ancient Ayurveda system of medicine in India but also in traditional Chinese, Roman, and Greek medicine. “Let food be thy medicine and medicine be thy food," as Hippocrates (460-377 BC), the well-known father of modern medicine, declared, to emphasize the correlation between suitable foods for nutrition and their therapeutic effects. The guiding principle was “Focus on prevention”. Theophrastus (370–285 BC), Cato (234–149 BC), Pliny the Elder (23–79 AD), and Galan (131–201 AD) all issued statements warning against the adulteration of food products at that time. Since 2000 BC, Schwan has used microorganisms (fungi or yeast) 1837 to produce products through the alcoholic fermentation process. Funk (1884–1967), the father of vitamin therapy, started a new investigation on vitamins and identified them as nutritional required components for the survival of good health. Dr. Stephen L. De Felice, the chairman and founder of the innovation of medicine, coined the word "nutraceuticals." in 1989 by the combination of two words “nutrition” and “pharmaceutical”. Essentially, this is a marketing tool.
Summary of Chapters
I. Introduction: Outlines the historical context and foundational definitions of nutraceuticals and dietary supplements.
II. India’s regulation of nutraceuticals: Details the evolution of food laws in India and the establishment of the FSSAI.
III. Regulatory components for nutraceuticals: Specifies requirements for quality, composition, and labeling compliance.
IV. Licensing and registration of nutraceuticals: Describes the procedural steps and document requirements for obtaining manufacturing and import licenses.
V. Good Manufacturing Practices: Defines the facility standards needed to ensure product quality and hygiene.
VI. Method of preparation of nutraceuticals: Explains the extraction and production methods allowed under FSSAI regulations.
VII. Laboratory and sample analysis: Discusses the role of testing laboratories and the procedures for sample examination.
VIII. Labelling: Lists the mandatory information required on nutraceutical packaging.
IX. Claims and advertisements: Covers the legal requirements for making nutritional and health claims.
X. Recommended Dietary Allowances (RDA) in India: Summarizes the nutrient intake standards for different demographic groups.
XI. Food safety auditing: Explains the process and criteria for safety audits within the food industry.
XII. Recall guidelines: Outlines the strategies for identifying and recalling potentially hazardous products.
XIII. India’s nutraceutical marketing growth: Examines the economic potential and market trends for the industry in India.
XIV. Challenges in nutraceutical market: Reviews the obstacles firms face regarding regulation, quality, and awareness.
XV. Future developments: Highlights upcoming efforts in public education and scientific research.
XVI. Comparison of nutraceuticals in US, India, Europe: Provides a comprehensive benchmark of regulatory models.
Keywords
Nutraceuticals, FSSAI, DSHEA, EFSA, Dietary Supplements, Functional Foods, Food Safety, Regulatory Framework, GMP, Labeling, RDA, Clinical Trials, Licensing, Quality Control, Public Health.
Frequently Asked Questions
What is the core focus of this publication?
The publication focuses on the regulatory landscape of nutraceuticals in India and compares these standards with corresponding international regulatory systems in the US and Europe.
What are the primary sectors covered in the text?
The text covers categories such as dietary supplements, functional foods, medical foods, and novel foods, along with their production and safety standards.
What is the ultimate project objective?
The objective is to provide a study on nutraceutical regulations to help improve the understanding of how these products, which provide physiological benefits, are legally regulated to ensure product safety.
Which scientific methodologies are mentioned?
The publication covers methodologies ranging from GMP-compliant manufacturing processes and validated analytical testing (like HPLC, GC-MS) to clinical study requirements for health claims.
What topics are discussed in the main body?
The main body treats licensing procedures, laboratory analysis requirements, guidelines for product labeling, safety auditing processes, and market growth challenges in India.
Which keywords best characterize this work?
Keywords like Nutraceuticals, FSSAI, Regulatory Framework, GMP, and Food Safety are central to characterizing the regulatory and technical focus of the document.
How does the Indian regulatory approach differ from the US/EU models mentioned?
The document highlights differences in the classification of supplements, the stringency of clinical evidence required for claims, and the age and technological maturity of the respective agricultural processing industries.
What risks does the document associate with the current state of the Indian nutraceutical market?
The text notes risks such as inconsistent raw material quality, insufficient regulation of clinical studies, a lack of awareness among consumers, and the presence of unapproved counterfeit products.
- Quote paper
- Dr Shailaja Pashikanti (Author), Pagadala Bhagyalakshmi (Author), G. Snehalatha (Author), 2022, Nutraceutical Regulations in the Indian Market and Comparison with the United States and Europe, Munich, GRIN Verlag, https://www.grin.com/document/1298162
